Notification
No new Notification messages
Zinka Logistics Solutions IPO is Open!
Apply for the Zinka Logistics Solutions IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Shiva Pharmachem Limited

-

Offer Period :

Stanley Lifestyles, India's fourth-largest home furniture brand by revenue in 2022, boasts three decades of expertise. With state-of-the-art facilities and extensive artisan training, Read more... it offers premium furniture aligned with European quality standards. Expanding retail presence and innovative store formats cater to growing luxury furniture demand.Read less

Shiva Pharmachem Limited IPO Details

IPO Date - Minimum Investment ₹ / Lots
Listing Date Maximum Investment ₹ / Lots
Face Value ₹0 per share Total Issue Size ₹0 Crores
Price ₹0 to ₹0 per share Fresh Issue ₹0 Crores
Lot Size 1 Lots (0 Shares) Offer For Sale ₹ 0
Listing At Retail Discount ₹ 0
Employee Discount ₹0 per share    
IPO Date -
Listing Date
Face Value ₹0 per share
Price ₹0 to ₹0 per share
Lot Size 1 Lots (0 Shares)
Listing At
Employee Discount ₹0 per share
Minimum Investment ₹ / Lots
Maximum Investment ₹ / Lots
Total Issue Size ₹0 Crores
Fresh Issue ₹0 Crores
Offer For Sale
Retail Discount ₹ 0

Timeline

Important dates for allocation and IPO listing.

-

IPO Starts

-

IPO Ends

-

Allotment Date

-

Initiation of Refund

-

Credit of Shares to Demat Account

-

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 0 0
Public Group 0 0

Shiva Pharmachem Limited IPO Reservation

QIB Shares Offered 0(0%)
NII (HNI) Shares Offered 0(0%)
Retail Shares Offered 0(0%)
Anchor Investor Shares Offered 0(0%)
Total Shares Offered 0
Total Shares With Anchor Investor 0

IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)---
Retail (Max)---
S-HNI (Min)---
S-HNI (Max)---

Shiva Pharmachem Limited IPO Registrar

Link Intime India Pvt Ltd
Phone Number +91 810 811 4949
Email Id
Our Website www.linkintime.co.in

Shiva Pharmachem Limited IPO Lead Manager

1. JM Financial Ltd

2. Kotak Mahindra Capital Company Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Shiva Pharmachem Limited IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed

Strength of Shiva Pharmachem Limited

Risks Involved

1. The company derive a significant portion (more than 60%) of its revenue from operations from the company top 10 customers, with its single largest customer contributing more than 18% of its revenue from operations in Fiscal 2023. Loss of any of these customers or a reduction in purchases by any of them could adversely affect its business, results of operations and financial condition.

2. The company is depends on sales outside of India, which accounted for a significant portion (more than 70%) of its revenue from operations in each of the last three fiscal years. The demand of the company products outside India is subject to international market conditions and foreign regulatory risks that could adversely affect its business, results of operations and financial condition.

3. A significant portion (more than 40%) of its revenue from operations in each Fiscal 2023, Fiscal 2022 and Fiscal 2021 is attributable to customers operating in the agrochemicals sector. Any adverse changes in the agrochemicals sector or any other sector in which its large customers operate could adversely impact the company business, results of operations and financial condition.

4. The company business and profitability is substantially dependent on the availability and cost of its raw materials and the company is depends on third party suppliers, primarily outside of India, for meeting its raw material requirements which are on purchase order basis. Any disruption to the timely and adequate supply of raw materials, or volatility in the prices of raw materials may adversely impact the company business, results of operations and financial condition.

5. The company is depends on its R&D activities for its future success. If the company don't successfully develop new products or continue its product portfolio expansion in a timely and cost-effective manner, its business, results of operations and financial condition may be adversely affected.

6. The company has in the past received closure notice from Gujarat Pollution Control Board for our manufacturing facilities at Luna and Dahej SEZ in Gujarat.

7. The company manufacturing facilities are concentrated in Gujarat in India and Hungary in Europe. Any significant social, political, economic or seasonal disruption, natural calamities or civil disruptions in Gujarat or Hungary could have an adverse effect on its business, results of operations and financial condition.

8. The company is depends on third parties for the supply of utilities, such as water, gas and electricity, at its manufacturing facilities and any disruption in the supply of such utilities could adversely affect the company manufacturing operations. In addition, its utilities expenses have increased significantly since Fiscal 2021, and further increases in utilities expenses may impact its margins if the company is not able to pass these price increases to its customers.

9. The company is subject to certain risks consequent to its operations involving the manufacture, usage and storage of various hazardous substances.

10. The company may be subject to industrial unrest and increased employee costs, which may adversely affect its business and results of operations.

Why should you invest in

-

Financials

Particulars For the financial year ending (in ₹ million)
  2023 2022 2021
Total Assets 1156.94 1047 574.19
Total Liabilities 1156.94 1047 574.19
Total Expenses 940.04 919.83 458.7
Total Revenue 
1094.2 1031.83 559.38
Profit After Tax 112.75 82.55 75.22
EBITDA 218.92 175.6 129.41
Adjusted EBITDA 0 0 0

Shiva Pharmachem Limited IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
0 -
INE471Z01012
₹0 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹0 ₹0
Open ₹0 ₹0
Low ₹0 ₹0
High ₹0 ₹0
Low ₹0 ₹0

Frequently Asked Questions

What is Shiva Pharmachem Limited IPO?

Answer Field

Shiva Pharmachem Limited IPO is a [-] IPO of [-] equity shares of a face value of ₹[-] aggregating up to ₹[-] Crores. The issue is priced at ₹[-] to ₹[-] per share. The minimum order quantity is [-] Shares. The IPO opens on [-], and closes on [-]. Link Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on [-].

When Shiva Pharmachem Limited IPO will open?

Answer Field

The Shiva Pharmachem Limited IPO opens on [-] and closes on [-].

What is the lot size of Shiva Pharmachem Limited?

Answer Field

Shiva Pharmachem Limited lot size is [-] shares, and the minimum amount required is ₹[-].

How to apply for Shiva Pharmachem Limited IPO?

Answer Field

You can apply in Shiva Pharmachem Limited IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Shiva Pharmachem Limited IPO allotment?

Answer Field

The finalization of Basis of Allotment for Shiva Pharmachem Limited IPO will be done on [-], and the allotted shares will be credited to your demat account by [-].

When is Shiva Pharmachem Limited IPO listing date?

Answer Field

The Shiva Pharmachem Limited listing date is [-].

Who is the registrar of Shiva Pharmachem Limited IPO?

Answer Field

The registrar of Shiva Pharmachem Limited IPO is Link Intime India Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

JM Financial Ltd,Kotak Mahindra Capital Company Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Shiva Pharmachem Limited IPO?

Answer Field

The fresh issue size is ₹[-] Crores equity shares.

What minimum lot size can retail subscribers subscribe to Shiva Pharmachem Limited?

Answer Field

Retail investors can subscribe to a minimum of one lot, [-] shares and ₹[-] amount.

How can I approve the UPI mandate request for Shiva Pharmachem Limited IPO?

Answer Field

To apply for Shiva Pharmachem Limited IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Shiva Pharmachem Limited?

Answer Field

The price of each Shiva Pharmachem Limited share will be ranging in between ₹[-] to ₹[-] per share.

What is the cut-off time for the UPI mandate for Shiva Pharmachem Limited IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, [-].

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • DANISH POWER LIMITEDSME IPO

  • Issue Price

    380.00

  • Listing Day Close

    598.50

  • Listing Day (Gain/Loss)

    57.63

  • SHIV TEXCHEM LIMITEDSME IPO

  • Issue Price

    166.00

  • Listing Day Close

    250.95

  • Listing Day (Gain/Loss)

    51.20

  • SUBAM PAPERS LIMITEDSME IPO

  • Issue Price

    152.00

  • Listing Day Close

    149.10

  • Listing Day (Gain/Loss)

    -1.97

  • SAJ HOTELS LIMITEDSME IPO

  • Issue Price

    65.00

  • Listing Day Close

    52.45

  • Listing Day (Gain/Loss)

    -20.00

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text